RECURRENT NASOPHARYNGEAL CARCINOMA
Clinical trials for RECURRENT NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo aims to stall return of rare throat cancer
Disease control Recruiting nowThis study is for people with a type of throat cancer (nasopharyngeal carcinoma) that has come back or spread. After initial chemotherapy and immunotherapy, participants receive either the standard immunotherapy (nivolumab) alone or combined with another drug (relatlimab) to see …
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New Low-Temperature surgery could improve survival in recurrent nasal cancer
Disease control Recruiting nowThis study compares two surgical techniques for people whose nasopharyngeal cancer has come back after initial treatment. Half the participants will receive a newer, low-temperature plasma ablation, while the other half will receive standard high-frequency electrocautery. The goa…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New hope for Tough-to-Treat throat cancer: drug cocktail shows promise
Disease control Recruiting nowThis study tests whether adding a targeted drug (cabozantinib) to a two-drug immunotherapy (nivolumab and ipilimumab) can help shrink or stabilize advanced nasopharyngeal cancer that has returned or spread. About 50 adults whose cancer progressed after platinum chemotherapy and i…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Proton beam takes aim at returning throat cancer
Disease control Recruiting nowThis study is testing a precise type of radiation called proton therapy for people whose nasopharyngeal cancer has come back. The goal is to see if it can control the cancer while causing fewer severe side effects than standard treatments. About 52 adults with recurrent, non-spre…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immunotherapy boost may improve outcomes in returning throat cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (PD-1 antibody) to standard chemoradiotherapy helps people with recurrent nasopharyngeal carcinoma live longer. About 212 participants whose cancer has returned after prior treatment and cannot be surgically removed wi…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC